Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Add as a preferred source on Google
IRVINE, Calif., April 25, 2018 -- Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) announced today that it will issue its 2018 first quarter earnings release on May 9, 2018.
A conference call with a simultaneous webcast to discuss the 2018 first quarter earnings will be held on Thursday, May 10 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 6176379.
The webcast URL is https://edge.media-server.com/m6/p/on7ijarn
A digital replay of the call will be available on our website at www.sabrahealth.com.
ABOUT SABRA
Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
CONTACT
Investor & Media Inquiries: 1-888-393-8248 or [email protected]
